1. Introduction {#sec0005}
===============

Approximately 100 trillion microorganisms exist in the human body; however, little information about the role and character of these commensal bacteria has been reported.

Recently, it was proposed that the human body establishes a symbiotic relationship that contributes to the maintenance of immune function by providing a niche for commensal bacteria called as microbiome [@bib0005], [@bib0010], [@bib0015]. Currently, the study of microbiomes in the human body is progressing via comprehensive gene analyses, using samples collected from saliva, skin, and feces [@bib0020], [@bib0025], [@bib0030]. Because the constitution patterns of the intestinal flora are of an infinite variety among humans, microbiomes may affect human physical and mental health because of their diversity [@bib0015], [@bib0035], [@bib0040]. It can be said that the study of microbiomes has changed the traditional concepts of microbial research.

In the process of indigenous flora formation, it is necessary to colonize the host by adapting to external stresses, including the immune system. Furthermore, bacteria must also compete with other commensal bacteria.

In the oral cavity, several hundreds of bacterial species exist, forming a complex bacterial floral community [@bib0045]. Oral flora, as well as intestinal flora, are also expected to exert various effects on the host. Although many studies of oral bacteria have focused on the pathogenesis of cariogenic bacteria and periodontal bacteria, future research on the association between oral flora and the host has attracted attention.

We first focused on *Streptococcus mutans*, a cariogenic bacteria, and sought to elucidate the colonization mechanism of this organism in the oral cavity. *S. mutans* plays a key role in the formation of dental plaque, as well as in tooth decay, via the production of acids [@bib0050], [@bib0055], [@bib0060]. Although the mechanism underlying caries development due to *S. mutans* is known, it is not clear why this bacterium is able to reside in the oral cavity. There are numerous antimicrobial agents in the oral cavity, and resistance to these antimicrobial agents is largely responsible for the colonization of *S. mutans.* To form the biofilm (dental plaque) physical barrier to resist the antimicrobial agents. Furthermore, bacteria including *S. mutans* possess two-component systems (TCSs) which sense the environmental stimuli including antimicrobial agents and regulate the expressions of several factors to be responsible for the adaptation to the stimuli.

Two-component systems are prokaryote-specific signal transduction systems that comprise a sensory histidine kinase (HK) and a cognate response regulator (RR) [@bib0065]. The sensory HK undergoes autophosphorylation of a histidine residue in response to an environmental signal and relays the phosphate group to an aspartic acid residue on the cognate RR [@bib0070], [@bib0075]. The phosphorylated RR then binds to target DNA elements with strong affinity, activating or repressing transcription of target genes ([Fig. 1](#fig0005){ref-type="fig"}). We focused on the relationship between TCSs and resistance to antimicrobial peptides. Through these results, we have gained new knowledge of the above phenomena.Figure 1Scheme of the two-component system. The sensory histidine kinase undergoes autophosphorylation of a histidine residue in response to an environmental signal and relays the phosphate group to an aspartic acid residue on the cognate response regulator (RR). The phosphorylated RR then binds to target DNA elements with strong affinity, activating or repressing the transcription of target genes.Figure 1

In this review, we present an overview of antimicrobial peptides and TCSs, including the results of our study regarding the acquisition of resistance mechanisms in *S. mutans* against human- and bacteria-derived antimicrobial peptides.

2. Human-derived antimicrobial peptides {#sec0010}
=======================================

In the oral cavity, there are many antimicrobial factors, such as antimicrobial peptides, lysozymes, hydrogen peroxide and lactoferrin [@bib0080], [@bib0085]. Among these antibacterial factors, antimicrobial peptides are believed to have bactericidal activity against various oral bacteria, including cariogenic and periodontopathogenic bacteria [@bib0085]. Human-derived antimicrobial peptides originate from various sources, such as the saliva, gingival epithelium, mucosa, neutrophils and gingival crevicular fluid [@bib0090], [@bib0095]. These peptides are considered the first defense against bacterial infections as a form of innate immunity. [Fig. 2](#fig0010){ref-type="fig"} shows the varieties of human-derived antimicrobial peptides.Figure 2Antimicrobial peptides in humans. LL37 has a linear form. Defensins produced by humans are classified into two types: alpha- and beta-defensins. Defensins have three disulfide bonds among 6 cysteines in peptides. Histatins are salivary antimicrobial peptides and are a family of histidine-rich cationic peptides produced by parotid and salivary duct cells. Histatins are known to have antifungal activity. Histatin 5, in particular, has strong activity against fungi, including *Candida* species.Figure 2

2.1. Defensins {#sec0015}
--------------

Defensins have three disulfide bonds among 6 cysteines in peptides, which distinguishes them from other antimicrobial peptides. Defensins are further classified into three types: alpha-, beta- and theta-defensins, although theta defensins are not expressed in humans [@bib0090], [@bib0100], [@bib0105]. Differences in producing cells and the arrangement of the 3 disulfide bonds distinguish alpha- and beta- defensins.

Several alpha- defensins (human neutrophil defensin: HNP) have been identified. HNP1-4 is mainly localized in the granules of neutrophils, whereas HNP5 and 6 are localized in the Paneth cells of the small intestine [@bib0110]. HNPs demonstrate broad antimicrobial activity against Gram-positive and -negative bacteria, fungi and viruses. The activity of these peptides is decreased by high NaCl concentrations. In addition to antimicrobial activity, several HNPs are reported to have chemotactic activity as cytokines.

To date, 4 beta-defensins (human neutrophil defensing 1--4: HBD1-4) have been reported. These peptides are expressed in various epithelial tissues, such as the skin, trachea, gingiva and saliva [@bib0110], [@bib0115], [@bib0120], [@bib0125]. In vitro experiments, HBD1 are constitutively expressed, while HBD2 and HBD3 are inducible [@bib0115], [@bib0120], [@bib0125], [@bib0130], [@bib0135], [@bib0140]. Additionally, HBD1 and HBD2 have been demonstrated to have strong activity against Gram-negative bacteria, but not Gram-positive bacteria, while HBD3 and HBD4 have strong activity against both types of bacteria [@bib0145], [@bib0150], [@bib0155], [@bib0160]. Like HNPs, HBDs also have chemotactic activity against human cells [@bib0165], [@bib0170].

2.2. Cathelicidins {#sec0020}
------------------

The cathelicidin family features characteristic conserved domains known as cathelins (cathepsin inhibitors) in their N-terminal and variable regions and C-termini with antimicrobial activity. In humans, only one cathelicidin, known as LL37, has been identified [@bib0095], [@bib0175]. LL37 is found in various cells, such as neutrophils, monocytes and various epithelial cells [@bib0175]. Unlike defensins, LL37 has no disulfide bonds and has a linear form. LL37 has strong antibacterial activity against Gram-negative and -positive bacteria [@bib0095], [@bib0180]. LL37 is also known as LPS neutralizing factor, which binds LPS and inhibits endotoxin activity [@bib0095], [@bib0185]. Moreover, LL37 has chemotactic activity against various cells, such as neutrophils, monocytes and mast cells [@bib0190].

2.3. Histatins {#sec0025}
--------------

Histatins are salivary, cationic antimicrobial peptides and are a histidine-rich family produced by parotid and salivary duct cells [@bib0195]. Histatins are known to have antifungal activity. In particular, histatin 5 has strong activity against fungi, including Candida species [@bib0200].

3. Bacteria-derived antimicrobial peptides (bacteriocins) {#sec0030}
=========================================================

The antibacterial agents produced by bacteria are called bacteriocins. Bacteriocins are ribosomally synthesized peptides, or proteins that exhibit antibacterial activity, mostly against bacterial species that are closely related to the bacteriocin producer [@bib0205], [@bib0210]. Bacteriocins are mainly classified into classes I and II [@bib0215]. Class I bacteriocins (peptides \<5 kDa) are called "lantibiotics" and contain a ring bridged by lanthionine and 3-methyllanthionine residues [@bib0220], whereas class II bacteriocins comprise unmodified amino acids [@bib0225]. Lantibiotics are further classified to Type A-I, Type A-II, and Type B by view of their similarities to peptides with established structures [@bib0215]. [Table 1](#tbl0005){ref-type="table"} shows the list of lantibiotics. Many bacteria produce bacteriocins to ensure their survival in this community [@bib0210], [@bib0230]. To persist in the oral cavity, bacteria must possess several factors to resist not only host immune factors but also bacteriocins from other microfloral species. The mode of action of bacteriocins is believed to involve pore formation in the cell membrane or inhibition of cell wall synthesis. [Fig. 3](#fig0015){ref-type="fig"} shows the antibacterial mechanism of nisin A, which is a typical bacteriocin produced by *Lactococcus lactis*. Nisin A can bind to the lipid II moiety, which is related to the biosynthesis of cell wall peptidoglycan [@bib0210], [@bib0215]. Therefore, the mode of action of nisin A is pore formation and inhibition of cell wall synthesis.Figure 3Antibacterial mechanism of nisin A. Nisin A interferes with cell wall biosynthesis and forms complexes with lipid I and lipid II. Subsequently, nisin affects the cytoplasmic membrane of susceptible bacteria and is able to form short-lived pores in the cell membrane. This effect leads to an efflux of small molecules (potassium, ATP, and amino acids) and dissipation of the membrane potential, resulting in the arrest of all cellular biosynthesis.Figure 3Table 1Classification of bacteriocins.Table 1ClassCharacteristicsRepresentative bacteriocinsILantibiotics, small (\<5 kDa) heat-stable peptides containing unsaturated amino acids, lanthionine and 3-methyllanthionine AIMore elongated peptides than Type-AIINisin, mutacin I, II, III, 1140, streptin AIIA linear N-terminus and a globular C-terminusLacticin 481, nukacin ISK-1, salivaricin, mutacin K8 BGlobular peptideMersacidin, cinnamycin othersTwo peptide lantibioticsLacticin 3147, staphylococcin C55, Smb  IISmall (\<10 kDa) heat-stable peptides formed by unmodified amino acids IIaAnti-listerial peptides with a consensus sequence of YGNGVXCPediocin PA-1, Enterocin A IIbTwo-peptide bactericinsLactococcin G, Lactococcin Q, Enterocin 1071 IIcOther bacteriocinsEnterocin B, Lactococcin A  IIIHigh-molecular-weight (\>30kDa), heat-labile proteinsHelveticin J, enterolysin A  IVComplex bacteriocins containing lipid or carbohydrate moietiesLeuconocin S, Lactocin 27  VCircular peptidesEnterocin AS-48, Lactocyclicin Q

4. Two-component systems {#sec0035}
========================

4.1. General characteristic of TCSs {#sec0040}
-----------------------------------

Recently, TCSs were reported to be associated with resistance to antibacterial agents, such as human- or bacteria-derived antimicrobial peptides. bacteria are able to quickly adapt to the external environment by regulating gene expression. Generally, bacteria possess multiple TCSs. It is believed that TCSs are involved in the adaptation to external stimuli, such as osmotic pressure, pH and temperature and virulence factor expression.

4.2. *S. mutans* TCSs {#sec0045}
---------------------

*S. mutans* UA159 possesses 15 sets of TCSs ([Table 2](#tbl0010){ref-type="table"}). Genome analysis of several *S. mutans* strains showed that more than 12 TCSs are conserved among *S. mutans* strains [@bib0235]. Each TCS is believed to have a role; however, the functions of some TCSs are unknown. ComDE is known as a quorum sensing system, which is a sensor of cell density in biofilm and is also related to competence [@bib0240], [@bib0245]. VicRK is also conserved among many bacterial species and is related to virulence [@bib0250], [@bib0255]. Due to the characteristics of *S. mutans*, the relationship between TCSs and biofilm formation and acid tolerance has been well-demonstrated [@bib0250], [@bib0260], [@bib0265], [@bib0270]. To date, several TCSs have been reported to be associated with acid tolerance and biofilm formation, although the precise mechanism underlying these linkages has not been elucidated. Regarding antimicrobial agents, it was reported that ComDE (SMU. 1916--17) is associated with production of the bacteriocin known as mutacin IV [@bib0240].Table 2Two-component systems in *S. mutans* UA159.Table 2Gene IDGene nameFunctionSMU_486-487*liaRS*Envelope stress, acid torelance, biofilm formationSMU_577-576unassignedUnknownSMU_660-659*nsrRS*Nisin resistanceSMU_928-927unassignedLow nutritionSMU_1009-1008*bceRS*Bacitracin resistanceSMU_1037-1038unassignedUnknownSMU_1128-1129*ciaRH*Acid tolerance,competence, resistance against cationic agentsSMU_1145-1146*lcrRS*Nukacin resistanceSMU_1516-1517*vicRK*Biofilm, oxidative stressSMU_1548-1547unassignedUnknownSMU_1814-1815unassignedOxidative stressSMU_1916-1917*comDE*MutacinIV production, competencySMU_1965-1964unassignedUnknownSMU_1924*gcrR*GbpC expression, biofilm formationSMU_45-46unassignedOxidative Stress

5. Association of TCS with antimicrobial susceptibility in *S. mutans* {#sec0050}
======================================================================

5.1. Resistance to human antimicrobial agents {#sec0055}
---------------------------------------------

First, we evaluated susceptibility to LL37 and β-defensins using 15 sets of TCS knockout mutants. As a result of this comprehensive analysis, one TCS (*ciaRH*) knockout mutant showed increased susceptibility to LL37 and beta-defensins (HBD1-3) in biofilm cells [@bib0275]. Further experiments showed that CiaRH regulates the *dlt* operon, which plays an important role in the acquisition of resistance to positively-charged antimicrobial agents, such as LL37 and β-defensins. In biofilm cells, *dlt* expression in a *ciaRH* knock-out mutant was decreased compared with the wild type. Normally, the bacterial cell surface is negatively charged, and positively charged antimicrobial peptides are attracted to the membrane. Dlt was reported to be a major contributor to the decreased negative charge of cell surfaces because the above factors are associated with the addition of alanine to teichoic acids [@bib0280], [@bib0285], [@bib0290]. Alanylation of teichoic acids in the cell wall conveys a positive charge to the bacterial cell surface, which results in a shift to a weak negative charge on the cell surface [@bib0285], [@bib0290]. Our results suggest that CiaRH is related to the expression of *dlt* in biofilm cells and contributes to resistance to positively-charged antibacterial agents by weakening the negative change of the cell surface ([Fig. 4](#fig0020){ref-type="fig"}).Figure 4Scheme of the resistance mechanism against antimicrobial peptides via the CiaRH-Dlt system in *S. mutans*. CiaRH is related to the expression of *dlt* in biofilm cells and contributes to resistance to positively-charged antibacterial agents by weakening thenegative charge of the cell surface.Figure 4

5.2. Resistance to bacteria-derived antimicrobial agents (bacteriocins) {#sec0060}
-----------------------------------------------------------------------

The susceptibility of the *S. mutans* wild type and its TCS knockout mutants was examined by direct methods using a variety of bacteriocin-producing bacteria. The susceptibility of three class I bacteriocins, including nisin A, nukacin ISK-1 and lacticin 481, and 3 class II bacteriocins, including types IIa-IIc, was evaluated. As a result, the knockouts of two unidentified TCSs (designated NsrRS and LcrRS) showed decreased susceptibility to bacteriocins, while the other mutants showed no change [@bib0295]. The knockout of the genes SMU.658--59, designated *nsrRS*, caused increased susceptibility to nisin A, a class I lantibiotic produced by *L. lactis*. In *nsrRS* mutants, the gene designated *nsrX* was not increased by the addition of nisin A, while *nsrX* expression was increased by nisin A in the wild type. Finally, we demonstrated that NsrX was expressed on the cell membrane and had binding affinity for nisin A, causing the trapping of nisin A to inhibit binding of nisin A to the target ([Fig. 5](#fig0025){ref-type="fig"}).Figure 5Proposed bacteriocin resistance mechanism mediated by TCSs in *S. mutans.* BceRS is related to bacitracin resistance by regulating BceAB ABC transporter. NsrRS is related to nisin A resistance by regulatiing NsrX which has ability to bind nisin A, suggesting trap nisin A. LcrRS is related to nukacin ISK-I and lacticin 481 resistance by regulating LctFEG ABC transporter.Figure 5

The knockout of the genes SMU.1146--47, designated *lcrRS*, caused increased susceptibility to nukacin ISK-1, which is a class I lantibiotic produced by *Staphylococcus warneri.* The expression of the ABC transporter *lctFEG*, which is located downstream of *lcrRS*, was inhibited by exposing nukacin ISK-1 in In *lcrRS* knockout mutants. This result suggested that the expression of LctFEG was induced by nukacin ISK-1 via LcrRS ([Fig. 5](#fig0025){ref-type="fig"}). Therefore, the functions of NsrX and LctFEG are thought to be different: NsrX binds nisin A and captures nisin A to avoid attachment to the cell membrane; however, LctFEG may export nukacin ISK-1. In other reports, BraRS and LiaRS were demonstrated to be involved in bacitracin and vancomycin susceptibility, respectively [@bib0300], [@bib0305]. Also, ComDE was reported to be involved in Mutacin IV Production [@bib0240]. Therefore, totally 5 TCSs are associated with bacteriocin.

Deng et al. reported that VicRK, one of the TCSs in *S. mutans*, was associated with hydrogen peroxide (H~2~O~2~) stress [@bib0310]. Although this result was reconfirmed in our study, it is unclear which resistant factors are regulated by VicRK. It is known that *Streptococcus sanguinis* produces H~2~O~2~. This bacteria is one of the major commensal bacteria in the oral cavity. We expected that VicRK systems in *S. mutans* play an important role in resisting the H~2~O~2~ produced by *S. sanguinis*.

5.3. Bacteriocin affects the proportion of bacteria when two bacteria are co-cultured {#sec0065}
-------------------------------------------------------------------------------------

To determine whether bacteriocins are important for persistent survival in complex bacterial communities, we established a co-culture assay to evaluate each bacterial proportion when two bacterial strains were mixed and cultured [@bib0295]. When wild type *S. mutans* was co-cultured with bacteriocin-producing or nonproducing strains, the proportion of *S. mutans* co-cultured with bacteriocin-producing strains was decreased compared to that co-cultured with bacteriocin-nonproducing strains. Additionally, when the respective TCS mutants were co-cultured with bacteriocin-producing strains, the proportion was significantly decreased compared to the WT. These results indicate that bacteriocin and TCS-mediated bacteriocin resistance are important for survival in complex bacterial communities.

6. Conclusions {#sec0070}
==============

In our study, 3 of the 15 TCSs identified in *S. mutans* were demonstrated to be associated with resistance to human- or bacteria-derived antimicrobial peptides [@bib0275], [@bib0295]. Furthermore, other researchers reported that 3 additional TCSs were associated with production of or resistance to antibacterial agents [@bib0240], [@bib0300], [@bib0305].

In particular, four TCSs have been identified as bacteriocin-related factors ([Figure 4](#fig0020){ref-type="fig"}, [Figure 5](#fig0025){ref-type="fig"}). These results highlight the role of bacteriocins in the interactions among different species of oral bacteria and the importance of TCSs in these interactions. In the oral cavity, TCSs play an important role in acquiring resistance to human- or bacteria-derived antimicrobial agents.

It is suggested that bacterial TCSs may be key factors in understanding the colonization mechanisms of commensal bacteria in humans. In recent years, it has been reported that intestinal bacterial microbiomes have a large impact on human health. In the process of microbiome formation, we considered that TCSs play an important role in adapting to the environmental stimuli that arise from interactions between bacteria and the human body. In the future, we expect to examine whether TCSs are involved in microbiome formation.

In addition, in this study, it was suggested that antimicrobial factors, including human- and bacteria-derived antimicrobial peptides, are strongly associated with commensal flora formation, including oral flora formation. Further examinations are needed to analyze microbiome formation.

Conflicts of interest {#sec0075}
=====================

None.

Scientific field of dental sciences: oral bacteriology.
